The World Health Organisation (WHO) on Wednesday said that clinical trials of the drug hydroxychloroquine would resume. "On the basis of the available mortality data... the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm," WHO chief Tedros Adhanom Ghebreyesus said